Smart Genetics Responds to Passage of GINA in U.S. SenatePhiladelphia, PA, April 24, 2008 — Julian Awad, CEO of the Philadelphia-based genetic risk assessment firm Smart Genetics, issued the following statement following U.S. Senate passage of the Genetic Information Nondiscrimination Act (GINA): Today the U.S. Senate took another important step in strengthening federal laws that protect the privacy of our medical information, in this case genetic test results. GINA will make it possible for individuals to gain insight into their genetic code without any fear that their employer or insurance provider is peering over their shoulder at their test results. As a result of this legislation, no American should face discrimination based on the content of his or her genetic code. I applaud the U.S. Senate for passing this important legislation. We trust that the U.S. House of Representatives will follow suit and that President Bush will sign it into law soon. About Alzheimer’s Mirror (www.alzmirror.com) Alzheimer’s Mirror™ is a comprehensive service providing risk assessment, education and personalized tools to help individuals plan for the possibility of developing Alzheimer’s disease. Alzheimer’s Mirror™ is the only Alzheimer’s risk assessment service to examine all three parts of the APOE gene, each of which is critical to assessing an individual’s overall risk. It is also the only service of its kind that takes into consideration non-genetic risk factors, such as family history, age and gender so that individuals have a more complete understanding of their risk profile. Alzheimer’s Mirror is based on the National Institutes of Health’s landmark REVEAL study, which found that with proper education and screening, APOE disclosure is safe and beneficial. About Smart Genetics Smart Genetics is a Philadelphia-based, direct-to-consumer genetic testing firm dedicated to providing consumers with meaningful and relevant health-risk assessments. For interviews with Mr. Awad, contact Al Shaine at (202) 478-3562. ### |